Pictet Asset Management (Switzerland)’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
$228K Sell
8,991
-2,779
-24% -$70.3K ﹤0.01% 1655
2023
Q1
$379K Buy
+11,770
New +$379K ﹤0.01% 1381